Medical, Pharma, Engineering, Science, Technology and Business

**Vatcheva KP ^{1}, Lee M^{3,4}, McCormick JB^{1}and Rahbar MH^{2,3,4*}**

^{1}Division of Epidemiology, University of Texas Health Science Center-Houston, School of Public Health, Brownsville Campus, Brownsville, TX, USA

^{2}Department of Epidemiology, Human Genetics, and Environmental Sciences (EHGES), University of Texas School of Public Health at Houston, Houston, TX, USA

^{3}Division of Clinical and Translational Sciences, Department of Internal Medicine, Medical School; The University of Texas Health Science Center at Houston, Houston, TX, USA

^{4}Biostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences (CCTS), The University of Texas Health Science Center at Houston, Houston, TX, USA

- Corresponding Author:
- Mohammad H. Rahbar PhD

University of Texas Health Science Center at Houston

Biostatistics/Epidemiology/Research Design

Component of Center for Clinical and Translational Sciences

6410 Fannin Street, UT Professional Building Suite 1100.05

Houston, TX 77030, USA

**Tel:**(713)500-7901

**Fax:**(713)500-0766

**E-mail:**[email protected]

**Received Date:** November 01, 2014 **Accepted Date:** January 12, 2015 **Published Date:** January 15, 2015

**Citation:**Vatcheva KP, Lee M, McCormick JB, Rahbar MH (2016) The Effect of Ignoring Statistical Interactions in Regression Analyses Conducted in Epidemiologic Studies: An Example with Survival Analysis Using Cox Proportional Hazards Regression Model. Epidemiol 6: 216. doi:10.4172/2161-1165.1000216

**Copyright:** © 2016 Vatcheva KP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

**Visit for more related articles at** Epidemiology: Open Access

**Objective:** To demonstrate the adverse impact of ignoring statistical interactions in regression models used in epidemiologic studies.

**Study design and setting:** Based on different scenarios that involved known values for coefficient of the interaction term in Cox regression models we generated 1000 samples of size 600 each. The simulated samples and a real life data set from the Cameron County Hispanic Cohort were used to evaluate the effect of ignoring statistical interactions in these models.

**Results:** Compared to correctly specified Cox regression models with interaction terms, misspecified models without interaction terms resulted in up to 8.95 fold bias in estimated regression coefficients. Whereas when data were generated from a perfect additive Cox proportional hazards regression model the inclusion of the interaction between the two covariates resulted in only 2% estimated bias in main effect regression coefficients estimates, but did not alter the main findings of no significant interactions.

**Conclusions:** When the effects are synergic, the failure to account for an interaction effect could lead to bias and misinterpretation of the results, and in some instances to incorrect policy decisions. Best practices in regression analysis must include identification of interactions, including for analysis of data from epidemiologic studies.

Effect modification; Cox proportional hazards model; Regression analysis; Simulation; Statistical interaction; Type 2 diabetes

The terms interaction effect and effect modification, or effectmeasure modification are often used interchangeably, particularly for health related research in epidemiology [1]. From an epidemiologic prospective effect modification refers to a situation where the effect of one predictor variable (e.g., exposure) on the outcome is dependent on the values of some other covariates [1,2]. From a statistical prospective, an interactive multivariable regression model could be fit by including the product of two or more predictor variables along with their corresponding individual variables in regression models [1].

Identification of statistical interactions in a regression model is important because this could lead to significant public health implications. For example, using data from an Epidemiologic Study on the Insulin Resistance Syndrome (DESIR) cohort, Gautier A. et al. (2010) found significant interactions between baseline BMI categories and higher waist circumference in relation to progression to type 2 diabetes using a logistic regression model [3]. Based on their findings the authors concluded that for reducing incidence of type 2 diabetes in their study population, it is important to monitor and prevent increases in waist circumference, particularly for those with BMI <25 kg/m^{2}. Similarly, Hanai K. et al. examined whether obesity modifies the association of serum leptin levels with the progression of diabetic kidney disease by including an interaction term between the obesity and leptin in a Cox proportional hazards regression model [4]. The authors found a significant interaction between leptin levels and obesity, hence concluded that obesity modifies the effect of leptin on kidney function decline in patients with type 2 diabetes. On the other hand, in an Iranian sex-stratified cohort study which was conducted to investigate risk factors for incidence of type 2 diabetes using Cox proportional hazards regression model [5], the authors recommended different preventive strategies by sex because of their findings that along with central adiposity in women and general adiposity in men, a lower education level conferred a higher risk for incidence of diabetes among men. Using data from Second Manifestations of Arterial Disease (SMART) study, Verhagen S. N. et al. investigated the relation between high-sensitivity C-reactive protein (hsCRP) levels and the incidence of type 2 diabetes in patients with manifest arterial disease or any cardiovascular risk factors [6]. The authors found a significant interaction between gender and hsCRP in relation to incidence of type 2 diabetes in a Cox proportional hazards model. They concluded that manifest arterial disease patients with high hsCRP plasma levels are at increased risk to develop type 2 diabetes and this risk is more pronounced in female than male patients.

While some epidemiologic studies investigated and found significant interactions or effect modifications, in a majority of epidemiologic studies the interactions or effect modifications are not explored. We estimated the relative frequency of lack of exploring potential interactions in regression analyses by conducting a nonsystematic search in PubMed for the period, January 2004 to December 2013. Since interactions and effect modifications are usually explored via multivariable regression models and different terms such as “multivariable regression” or “multiple regressions” or “regression” are used in regression analysis [7], we restricted our search only to “multivariable regression” and “multiple regression”, which are often used interchangeably by epidemiologists. Next, among papers using the terms “multivariable regression”, “multiple regression” or “regression”, we searched for the terms “statistical interaction”, “effect modifier”, “effect modification”, or “heterogeneity of effect”. The result revealed that 4.4% of the published studies in PubMed that used terms “multivariable regression” (or “multiple regression”) have used terms related to interactions, effect modifications, or heterogeneity of effects in their publications.

Although some of the publications may not be related to epidemiologic studies, or the terms interaction or heterogeneity may be used under different context, our search revealed that a majority of investigators may not explore interactions or effect modifications when conducting regression analysis.

The aim of this study is to demonstrate the adverse effects of ignoring interactions in regression models by conducting simulation studies in different scenarios. Specifically, we study the effect of ignoring interactions in a Cox proportional hazards regression model. In addition, to demonstrate the importance of including interactions in regression models in real life epidemiologic studies, we compared results from additive and interactive models using data from the Cameron County Hispanic Cohort (CCHC) [8]. For this we specifically focused on investigating the role of peripheral white blood cells (WBC) counts, WBC differential counts and BMI in association with the time to incidence of type 2 diabetes while controlling for the effect of other known type 2 diabetes risk factors.

**Simulation study for investigating interactive effects**

Dataset generation: To assess the impact of ignoring the interactive effects, we simulated data from two fully specified Cox proportional hazards regression models *h(t|x)=h _{0}(t)exp(β′x)* where h(t|x) is the hazard rate at time t for an individual with risk vector x, β is the vector of regression coefficients, and h

Scenario | Cox proportional hazards regression model* |
---|---|

1 | h(t/ x)=h_{0} (t) exp (2x_{1}+x_{2}) |

2 | h(t/ x)=h_{0} (t) exp (2x_{1}+x_{2}+0.5x_{1} x_{2}) |

3 | h(t/ x)=h_{0} (t) exp (2x_{1}+x_{2}+x_{1} x_{2}) |

4 | h(t/ x)=h_{0} (t) exp (2x_{1}+x_{2}+1.5x_{1} x_{2}) |

*The values of the regression coefficients were arbitrarily set for simulations.

**Table 1: **Cox proportional hazards regression models used for different scenarios of the simulation study

In order to simulate data from the underlying Cox models, the effect of the covariates have to be translated from the hazard functions to the survival times, as documented in the literature [9,10]. It can be shown that the survival time for exponential survival random variable could be written as *T=-In[S(t)]/[λexp(β′x)] *, where S(t) is the probability of surviving beyond time t and λ>0 is the scale parameter of the exponential distribution. When S(T) has a uniform distribution between 0 and 1 (i.e., S(T)~U(0,1)) then-In[S(T)] is exponentially distributed with parameter 1, and T is exponentially distributed with parameter *λ′ (x)=λexp(β′x)*. To create survival time data we generated exponentially distributed survival times T with scale parameters λ′ (x)=λexp(β′x) with an arbitrarily chosen constant baseline hazard rate λ=h* _{0}*(t) [9,10]. Next, we generated exponentially distributed censoring time c with arbitrary chosen constant baseline censoring rate λ

**Model comparisons: **Using the simulated datasets Cox models with and without interaction terms were fitted under each of the scenarios. To summarize the simulation results, estimates for each regression coefficient and the corresponding standard errors from the 1000 replications were averaged for each of the scenarios.

For comparing coefficient estimates between correctly specified and misspecified Cox regression models percentage of bias was calculated using ,where is the average of the estimated regression coefficient over 1000 replications and β is the true value of the regression coefficient. Overall accuracy of the estimates was assessed by mean squared error (MSE) which is the sum of the variance of the estimator and the squared bias

All simulations were performed with Stata 12 [13] using survsim module [14,15] and the statistical analyses were performed using SAS 9.4 [16].

**Empirical example for demonstrating interaction effects using Cameron County Hispanic Cohort Data**

To demonstrate the importance of identifying interactions in epidemiologic studies, in this section we referred to an earlier finding from analyses of CCHC data with Cox proportional hazards regression model [8]. Briefly, using data from 636 participants in the CCHC, this study assessed crude and adjusted effects of total and differential WBC counts (lymphocytes, monocytes, and granulocytes), C-reactive protein (CRP), and Body Mass Index (BMI) in relation to time to progression to type 2 diabetes in Mexican Americans. All participants without any evidence of type 2 diabetes after the baseline visit, death or lost-tofollow up were considered as censored at their last observation dates. Other covariates, such as age at the time of the event or censoring, gender, family history of diabetes, pre-diabetes status, smoking, and triglycerides were also included in the regression analysis. The effect modification of continuous BMI and BMI levels (e.g., BMI<25 (normal), 25 ≤ BMI<30 (overweight), and BMI ≥30 (obese)) on total and differential WBC counts were evaluated. In this study, the presence of the interactions was tested by including the product of the dichotomized BMI as BMI ≥35 and BMI <35 with total or differential WBC counts in the models [17] and by using a likelihood ratio test for the nested models with and without an interaction term. Also, we conducted multivariable Cox proportional hazards regression models stratified analyses by BMI categories to compare stratum specific hazard ratios with those obtained from our final interactive Cox proportional hazards regression models.

Cox proportional hazards regression model assumptions for the functional form of the continuous covariates (e.g., the linear relationship between log cumulative hazard and a covariate) and proportionality assumption of the hazards of all covariates were evaluated before and after including the interaction term in the model. Our result indicated that family diabetes history and pre-diabetes status did not satisfy the proportional hazards assumption; hence all models that included these two variables were stratified by these variables by including strata statement in SAS Proc Phreg [18]. Details regarding the model development are described elsewhere [8].

**Calculation of hazard ratios in the presence of interactive effects**

The calculations of Hazard Ratios (HRs) from an interactive Cox proportional hazards model is different from the calculations of HRs from an additive model. For example in the following interactive Cox proportional hazards model.

(1)

Where *x _{1}* is a continuous variable and

In contrast in an additive Cox proportional hazards regression model.

(2)

the HR for *x _{1}* is exp (

**Simulation study**

**Table 2** shows the results of the analysis of simulated data with Cox proportional hazards regression model (1) without the interaction term. The coefficient estimate for variable *x _{1}* in the correctly specified (model with no interaction term) and misspecified model (model with interaction term) had the same percentage of bias (0.5%) and MSE (0.01). However the estimate for coefficient of variable

Parameter estimates | Correct Model† | Misspecified Model‡ |
---|---|---|

Estimated coefficient of x_{1} ± SE |
2.01 ± 0.09 | 2.01 ± 0.11 |

%bias in estimated coefficient of x_{1} |
0.50% | 0.50% |

MSE* |
0.01 | 0.01 |

Estimated coefficient of x_{2} ± SE |
1 ± 0.12 | 0.98 ± 0.85 |

%bias in estimated coefficient | 0.00% | -2.00% |

MSE* | 0.02 | 0.72 |

Estimated coefficient of x_{1}*x_{2} (1 vs. 0) ± SE |
- | 0.003 ± 0.11 |

†Correct model is model with *no interaction term* x_{1}*x_{2} included; ‡Misspecified model is the model that *include interaction* term x_{1}*x_{2} in addition to x_{1} and x_{2} main effects; *Mean squared error is defined as the sum of the variance of the estimator and the squared bias.

**Table 2: **Findings from multivariable Cox proportional hazards regression model fitted using generated data in scenario 1.

**Table 3** shows the results of the analyses on simulated data with Cox proportional hazards models with interaction term under scenarios (2), (3) and (4). Compared to the correctly specified models, the regression coefficient estimates for variables *x _{1}* and

Parameter estimates | Data generated with b_{3}=0.5 (Model 2) |
Data generated with b_{3}=1.0 (Model 3) |
Data generated with b_{3}=1.5 (Model 4) |
|||
---|---|---|---|---|---|---|

Misspecified Model† | Correct Model‡ | Misspecified Model† | Correct Model‡ | Misspecified Model† | Correct Model‡ | |

Estimated coefficient of | 2.26 ± 0.09 | 2.01 ± 0.11 | 2.42 ± 0.09 | 2.01 ± 0.11 | 2.52 ± 0.1 | 2.01 ± 0.12 |

X_{1} ± SE |
||||||

%bias in estimated coefficient | 13.00% | 0.50% | 21.00% | 0.50% | 26.00% | 0.50% |

MSE* | 0.08 | 0.01 | 0.19 | 0.01 | 0.29 | 0.01 |

Estimated coefficient of X_{2} ± SE |
4.52 ± 0.21 | 1 ± 0.83 | 7.51 ± 0.3 | 1.04 ± 0.91 | 9.94 ± 0.39 | 1.03 ± 1.01 |

%bias in estimated coefficient | 352.00% | 0.00% | 651.00% | 4.00% | 894.00% | 3.00% |

MSE* | 12.43 | 0.7 | 42.49 | 0.85 | 80.18 | 1.03 |

Estimated coefficient of X _{1}*X_{2} ± SE |
- | 0.5 ± 0.12 | - | 1 ± 0.14 | - | 1.5 ± 0.16 |

%bias in estimated coefficient | 0.00% | 0.00% | 0.00% | |||

MSE* | 0.01 | 0.02 | 0.03 |

†Misspecified model is the model with no interaction term X_{1}*X_{2} included

‡Correct model is the model with interaction term X_{1}*X_{2} as well as the main effects of X_{1} and X_{2}

*Mean squared error is defined as the sum of the variance of the estimator and the squared bias

‡Correct model is the model with interaction term X

*Mean squared error is defined as the sum of the variance of the estimator and the squared bias

**Table 3:** Findings from multivariable Cox proportional hazards regression models fitted using generated data in scenarios 2, 3 and 4.

**Findings from the empirical study**

The results from the analyses of CCHC data are presented in **Tables 4** and **5** including estimates for the coefficients and their standard errors. In our final models we identified significant interactions between dichotomous BMI (i.e., obese categories) and total WBC (p-value=0.0137), granulocytes (p-value=0.0291), and lymphocytes (p-value=0.0478) after adjusting for the effect of age at the time of the event or censoring, gender, smoking, and triglycerides and stratified for family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg. Because of the significant interaction between dichotomous BMI and total WBC, granulocytes, and lymphocyte, we calculated estimated adjusted hazard ratios for WBC counts, granulocytes, and lymphocyte by different levels of the interacting variable BMI.

Variables | Unadjusted models* | Adjusted models* |
---|---|---|

HR (95% CI) | HR (95% CI) | |

Models with total WBC count x10^{9}/L: Hazard ratio for WBC by the level of the interacting variable BMI |
||

WBC in BMI≥35 | 1.29 (1.07-1.55) | 1.49 (1.20-1.85) |

WBC in BMI<35 | 1.09 (0.97-1.23) | 1.09 (0.97-1.85) |

Models with Lymphocytes x10^{9}/L: Hazard ratio for Lymphocytes by the level of the interacting variable BMI |
||

Lymphocytes in BMI≥35 | 2.60 (1.49-4.53) | 2.95 (1.57-5.52) |

Lymphocytes in BMI<35 | 1.45 (0.98-2.12) | 1.43 (0.98-2.09) |

Models with Monocytes x10^{9}/L: Hazard ratio for Monocytes by the level of the interacting variable BMI |
||

Monocytes in BMI≥35 | 3.36 (0.46-24.64) | 3.71 (0.44-31.19) |

Monocytes in BMI<35 | 1.88 (0.41-8.68) | 1.73 (0.40-7.42) |

Models with Granulocytes x10^{9}/L: Hazard ratio for Granulocytes by the level of the interacting variable BMI |
||

Granulocytes in BMI≥35 | 1.26 (1.00-1.60) | 1.49 (1.14-1.94) |

Granulocytes in BMI<35 | 1.06 (0.92-1.22) | 1.07 (0.92-1.23) |

Models with Granulocytes x10^{9}/L and Lymphocytes x10^{9}/L: Hazard ratio for Granulocytes by the level of the interacting variable BMI |
||

Granulocytes in BMI≥35 | 1.2 (0.95-1.52) | 1.46 (1.19-1.92) |

Granulocytes in BMI<35 | 1.02 (0.88-1.20) | 1.02 (0.86-1.20) |

*Models adjusted for age, gender, smoking, and triglycerides and stratified by family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg.

**Table 4: **Findings (SI units) from interactive multivariable Cox proportional hazards regression models of time to first type 2 diabetes using Cameron County Hispanic Cohort data, 2003-2014.

Variables | BMI groups | |
---|---|---|

BMI<35 | BMI≥35 | |

HR (95% CI) | HR (95% CI) | |

Models with total WBC count x10^{9}/L |
||

WBC | 1.10 (0.97, 1.24) | 1.47 (1.14, 1.89) |

Models with Lymphocytes x10^{9}/L |
||

Lymphocytes | 1.43 (0.98, 2.1) | 3.25 (1.58, 6.7) |

Models with Monocytes x10^{9}/L |
||

Monocytes | 1.80 (0.43, 7.55) | 3.13 (0.38, 26) |

Models with Granulocytes x10^{9}/L |
||

Granulocytes | 1.07 (0.92, 1.24) | 1.42 (1.06, 1.9) |

Models with Granulocytes x10^{9}/L and Lymphocytes x10^{9}/L |
||

Granulocytes | 1.04 (0.89, 1.22) | 1.36 (1.002, 1.83) |

*Models adjusted for age, gender, smoking, and triglycerides and *stratified* by family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg.

**Table 5: **Findings (SI units) from multivariable Cox proportional hazards regression models* for time to first type 2 diabetes among participants in BMI stratified Cameron County Hispanic Cohort, 2003-2014.

**Figure 1a** and **1b** present the plots of estimated adjusted hazard ratios for total WBC counts for BMI ≥35 and BMI<35 under a model with no interaction and a model including interaction term between BMI and total WBC counts. Under the additive model (i.e., with no interactions) the lines for the hazard ratios were somewhat parallel and the vertical distance between them represented the BMI adjusted hazard ratio for WBC counts (**Figure 1a**). The plot based on the interactive model (**Figure 1b**) shows departure from being parallel (i.e., constant adjusted Hazard Ratio) which was confirmed with the significant interaction between BMI levels and WBC (p-value=0.0137). The fact that the line for BMI ≥35 lies above the line for BMI<35 showed that the adjusted HR for BMI≥35 was greater than the adjusted HR for BMI<35 and this was confirmed for total WBC counts of greater than 5. The estimated adjusted HR for WBC in the model with no interaction after adjusting for the effect of BMI and the other diabetes risk factors was 1.09 [95% CI (0.97, 1.24)]. In the interactive model WBC was associated with progression to diabetes in participants with BMI ≥35 and the estimated adjusted HR was 1.49 [95%CI (1.20, 1.85)] while WBC was not significantly associated with progression to diabetes in participants with BMI<35 and the estimated adjusted HR was 1.09 [95%CI (0.97, 1.85)]. Similarly, **Figure 2a** and **2b** with two non-parallel lines present the HRs of granulocytes and lymphocytes respectively by the levels of BMI under the models with interaction, adjusting for the effect of age at the time of the event or censoring, gender, smoking, and triglycerides and stratified by family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg. Finally, **Figure 2c** presents the interaction effect between monocytes and BMI in relation to time to progression to type 2 diabetes and it shows that when monocytes were between 0 and 0.4, and 0.8 and 1.1 the HR lines for BMI≥35 and BMI<35 are approximately parallel, and the interaction effect between the two variables was not statistically significant (p-value=0.16).

The results from stratified analyses with multivariable Cox proportional hazards regression models by BMI categories are reported in **Table 5** which, are similar to those of the adjusted interactive models in **Table 4**. The results in **Table 5** reconfirm that the significant associations of total WBC counts, lymphocytes and granulocytes with progression to type 2 diabetes were only among participants with BMI≥35. Furthermore, the stratum specific HR estimates for each of the variables in **Table 5** were not similar indicating the presence of interaction effects of BMI with total WBC counts, lymphocytes and granulocytes.

In this paper we have demonstrated that a majority of epidemiologist and scientists do not report whether they have explored potential interactive effects when reporting their findings in publications that involve regression analysis. We have also examined the adverse effects of ignoring interactions when using a Cox proportional hazards regression model. We used simulation studies and data from the Cameron County Hispanic Cohort, to demonstrate detection, calculation of effects based on interactive models, and graphical presentation of interactive effects. The approach for the simulation studies was to first generate data from an additive model with known distributions and apply an additive (without their product term) Cox proportional hazards regression model with two covariates *x _{1}* and

Since this study focused on recognition of statistical interaction in regression analysis, in this paper we do not fully discus the findings from the CCHC data. However, the results from the CCHC prospective cohort study demonstrated with real life variables the difference between models with and without interaction term, more specifically the improvement of the inferences for hazard ratios for total WBC counts, granulocytes and lymphocytes after testing and identifying their interaction with dichotomous BMI ( BMI≥35 vs. BMI<35). The models with interaction terms revealed that WBC counts, lymphocyte and granulocyte were significant risk factors in the subjects with BMI ≥35. The presence of the interaction effects and the positive statistical association between total WBC counts, granulocytes and lymphocytes and progression to diabetes in individuals with BMI≥35 were confirmed when Cox proportional hazards regression models fitted separately in the BMI strata. Stratification is not only a technique to evaluate the presence of possible confounding but also allows for an evaluation of possible presence of interaction effect [1,2].

A key underlying assumption (assumption of proportional hazards) of the Cox proportional hazards model is that the hazard ratio is constant over time [1,18]. In our simulation studies and in the CCHC study the interactive variables met the proportional hazards assumption. However, stratification by the variable where this assumption does not hold is a popular solution to the problem by including strata statement in SAS Proc Phreg.

With the analyses of the simulated datasets and CCHC data we highlighted that failure to test for interaction effects in a regression analysis does lead to a significant bias in parameter estimates due to unaccounted interaction effect when it actually exists. We have also demonstrated calculation and interpretation of effects based on parameters estimates in a Cox regression models with a significant interactive effect. Statistical guidelines for best practices recommend assessment of interactions as one of the steps during the model building process [17,19]. Although the work presented here is based on Cox regression models, the findings from this study are generalizable to other regression models including linear, logistic, Poisson, and Negative binomial regression models.

Our studies have some limitations. These studies illustrated a two-way interaction effect between a continuous and a dichotomous variable. However in practice interaction effect may occur between continuous or categorical variables and it may even be represented by a higher order product terms. In addition in the Cox regression models to handle non-proportional hazards we used stratification in the variable where non-proportional hazards assumption was not met. However another method to handle non-proportional hazards is adding an interaction term between some function of time variable and the covariate which takes into consideration the non-constant influence of covariate on the hazard [20].

Since the main purpose of the study was to demonstrate the adverse effects of ignoring statistical interactions in regression models used in epidemiologic studies we did not use the developed sampling weights from the CCHC which were created to account for imbalances in the distribution of sex and age due to unequal participation of household members in the census tracts and to scale the sample to the population [21].

Our findings from a non-systematic review for this study revealed that a majority of published literature on epidemiologic studies that used multivariable regression models have not mentioned anything related to testing for statistical interactions, effect modification, or heterogeneity of effect. Although calculation and interpretation of interactive effects are more difficult these are essential if the effects are interactive or synergic. We recommend inclusion of interaction terms that are clinically significant even if the interaction effects are not statistically significant. The failure to identify interactive effects in regression models could lead to significant bias, misinterpretation of the results, and in some instances to incorrect public health interventions with potential adverse implications.

Part of this work was supported by the Center for Clinical and Translational Sciences, which is funded by National institutes of Health Clinical and Translational Award UL1 TR000371 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.

Research idea and study design: KPV, MHR, JBM; data acquisition: JBM; statistical analysis/interpretation: KPV; wrote the manuscript: KPV; reviewed/edited manuscript: MHR, ML, JBM. Each author: provided intellectual content; contributed significantly to the preparation and/or revision of the manuscript; and approved the final version of the manuscript. KPV takes responsibility for the integrity of the data and the accuracy of the data analysis.

- Kleinbaum DG, Kupper LL, Nizam A, Muller KE (2008) Applied Regression Analysis and Other Multivariable Methods. (4thedn), Duxbury Press.
- Szklo M, Nieto F (2007) Epidemiology: Beyond the Basics (2ndedn), Jones and Bartlett Publishers, Sudbury, MA.
- Gautier A, Roussel R (2010) Increases in Waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI. Diabetes care 33: 1850–1852.
- Hanai K, Babazono T, Takagi M, Yoshida N, Nyumura I et al. (2014) Obesity as an effect modifier of the association between leptin and diabetic kidney disease. J Diabetes Investig 5: 213-220.
- Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F et al. (2014) Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS One 9: e102563.
- Verhagen SN, Wassink AM, van der Graaf Y, Visseren FL, SMART Study Group (2013) C-reactive protein and incident diabetes in patients with arterial disease. Eur J Clin Invest 43: 1052-1059.
- Peters TJ (2008) Multifarious terminology: multivariable or multivariate? univariable or univariate?. PaediatrPerinatEpidemiol 22: 506.
- Vatcheva KP, Fisher-Hoch SP, Rahbar MH, Lee M, Olvera RL et al. (2015) Association of total and differential white blood cell counts to development of type 2 diabetes in Mexican Americans in Cameron County Hispanic Cohort. Diabetes Res Open J 1: 103-112.
- Bender R, Augustin T, Blettner M (2005) Generating survival times to simulate Cox proportional hazards models. Statistics in Medicine 24: 1713–1723.
- Burton A, Altman DG, Royston P, Holder RL (2006) The design of simulation studies in medical statistics. Statist Med 25: 4279-4292.
- Wicklin R Simulating data with SAS (2013) SAS Institute Inc., Cary NC, USA.
- Kleinman K, Horton JN (2014) SAS and R data management, statistical analysis and Grpahs. (2ndedn) Taylor&Francis Group, LLC.
- STATA. StataCorp. (2011) Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
- Crowther MJ, Lambert PC (2012) Simulating complex survival data. The Stata Journal 12: 674–687.
- Crowther MJ (2011) SURVSIM: Stata Module to Simulate Complex Survival Data, Statistical Software Components. Boston College Department of Economics: Boston.
- SAS 9.4 Software.
- Allison PD (1977) Testing for Interaction in Multiple Regression. American Journal of Sociology 83: 144-153.
- Hosmer D, Lemeshow S (1999) Applied survival analysis. Regression modeling time to event data, New York.
- Hosmer DW, Lemeshow S (2000) Applied logistic regression. (2ndedn), John Wiley& Sons, Inc.
- Allison PD (1995) Survival analysis using SAS: A practical guide Cary.
- Fisher-Hoch SP, Rentfro AR, Salinas J, Perez A, Brown HS, et al. (2010) Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007. Prev Chronic Dis 7: A53.

Select your language of interest to view the total content in your interested language

- A Healthcare Advertising
- Addiction
- Adolescence
- Advanced HIV Infection Preventive Measures
- Advanced Therapies
- Advanced Type 1 Diabetes Treatment
- Advanced Type 2 Diabetes Treatment
- Advances in HIV Diagnosis
- Advances in HIV Medications
- Advances in HIV Tests
- Advances in HIV Treatment
- Advances in Preventive Transmitted Disease
- Advances in health care
- Advances of Diabetes Cure
- Angelman Syndrome
- Antiretroviral Treatment
- Auto immune Disease
- Behavioral epidemiology
- Cancer epidemiology
- Causes of Down Syndrome
- Chicken Pox
- Childhood Diabetes
- Children Care
- Chronic Disease
- Ciprofloxacin
- Colon Infection
- Communicable Diseases
- Community Health
- Community Occupational Medicine
- Complications of Hyperglycemia
- Complications of Hypoglycemia
- Congenial Syndromes
- Conjunctivitis
- Cross-Sectional Study
- Cystic Fibrosis
- Diabetes Cholestrol
- Diabetes Clinical Trials
- Diabetes Lipid Metabolism
- Diabetes Research and Clinical Practice
- Diabetes Statistics
- Diabetes and Alcohol
- Diabetes and Kidney Disease
- Diabetes and Pregnancy
- Diabetes and Weight Loss
- Diabetes for Dummies
- Diabetic Amyotrophy
- Diabetic Cardiomyopathy
- Diabetic Eye Complications
- Diabetic Ketoacidosis
- Diabetic Nephropathy
- Diabetic Neuropathy
- Diabetic Nutrition
- Diabetic Peripheral Neuropathy
- Diabetic Retinopathy
- Diabetic Wound Care
- Disambiguation
- Disorders and Treatments
- Drug Resistance of HIV
- Economic epidemiology
- Education
- Emerging Infection
- Environmental epidemiology
- Epidemiology and Biostatistics
- Epidemiology and community health
- Epidemiology and disease control
- Epidemiology and infection
- Epidemiology of tuberculosis
- Ethical issues in Health care
- Etiology
- Family Medicine
- Feline Diabetes
- Fragile Syndrome
- Future of health care
- Gastroparesis
- Genetic Disorders
- Genetic Mutations in Humans
- Genetic epidemiology
- Global Health
- HIV Status
- HIV Super Infection
- HIV Vaccines
- HIV and AIDS Research
- HIV surveillance
- Health Insurances like
- Health Policy
- Health administration
- Health care communications
- Health care databases
- Health care economics
- Health care equipment
- Health care finance
- Health care innovation
- Health care insurance
- Health care insurance business
- Health care legislation
- Health care market analysis
- Health care products and market analysis
- Health care softwareÃ¢Â€Â™s
- Health care statistics
- Herpes Virus
- Highly Active Antiretroviral Therapy
- Human Papilloma Virus
- Infection
- Infection in Blood
- Infections
- Infections Prevention
- Infectious Diseases in Children
- Influenza
- Innovative HIV drugs
- Intestinal epidemiology
- Juvenile Diabetes
- Latest Research on Diabetes
- Mental Health Education
- Mitochiondrial Disease
- Mortality Rate
- Muscular Dystrophy
- Nephrogenic Diabetes Insipidus
- Nurse Practitioner
- Nutrition Education
- Nutrition epidemiology
- Obesity and Diabetes
- Occupational Therapy Education
- Oral/dental epidemiology
- Patau Syndromes
- Pathophysiology of Diabetes
- Pediatric epidemiology
- Population Health
- Prenatal Genetic Testing
- Prevalence
- Primary Care Sports Medicines
- Primary Care internal Medicine
- Primary Health Care
- Primary care epidemiology
- Renal epidemiology
- Reproductive Epidemiology
- Respiratory Tract Infections
- Reverse Diabetes
- Reye Syndromes
- Risk Analysis: HIV
- Risk Behaviours of HIV/AIDS
- Risk Factors
- Sexual Violence
- Sickel Cell Anemia
- Social & Preventive Medicine
- Social Service
- T Cell Lymphomatic Virus
- Tay-Sachs
- Treatment for Infectious Diseases
- Trends in maternal mortality
- Type 1 Diabetes
- Type 2 Diabetes
- Veterinary epidemiology
- Viral Encephalitis
- Women's Healthcare
- Yeast Infection

- Journal of Diabetic Complications & Medicine
- Journal of Diabetes & Metabolism
- Health Care : Current Reviews
- Primary Healthcare: Open Access
- Journal of Community Medicine & Health Education
- Journal of AIDS & Clinical Research
- Journal of Infectious Diseases and Therapy
- Journal of Genetic Syndromes & Gene Therapy

- 14th International Congress on
**Nutritional Epidemiology**and**Malnutrition**

Aug 28-30, 2017, Toronto, Canada - Annual Meeting on
**Viral Outbreaks**and**Epidemiology**

Oct 16-18, 2017, Baltimore, USA **9th****International Conference on Alzheimer’s Disease & Dementia**

October 16-18, 2017 Rome, Italy- 6th International Conference on
**Epidemiology**and**Public Health**

Oct 23-25, 2017, Paris, France

- Total views:
**7963** - [From(publication date):

February-2016 - Jul 22, 2017] - Breakdown by view type
- HTML page views :
**7893** - PDF downloads :
**70**

- Marelyn Hadaway
**Posted on**Oct 03 2016 at 5:30 pm

The work was methodologically very correct and also referred to as new important scientific findings could be useful for methodological discussions.

Peer Reviewed Journals

International Conferences 2017-18